First Manhattan’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.12M | Sell |
182,334
-7,527
| -4% | -$200K | 0.01% | 238 |
|
|
2025
Q4 | $4.73M | Sell |
189,861
-43,371
| -19% | -$1.09M | 0.01% | 239 |
|
|
2025
Q3 | $5.94M | Sell |
233,232
-24,132
| -9% | -$596K | 0.02% | 215 |
|
|
2025
Q2 | $6.24M | Sell |
257,364
-132,370
| -34% | -$3.09M | 0.02% | 201 |
|
|
2025
Q1 | $9.88M | Sell |
389,734
-32,967
| -8% | -$863K | 0.03% | 152 |
|
|
2024
Q4 | $11.2M | Sell |
422,701
-43,992
| -9% | -$1.19M | 0.03% | 138 |
|
|
2024
Q3 | $13.5M | Sell |
466,693
-92,708
| -17% | -$2.7M | 0.04% | 122 |
|
|
2024
Q2 | $15.7M | Sell |
559,401
-25,496
| -4% | -$702K | 0.05% | 120 |
|
|
2024
Q1 | $16.2M | Sell |
584,897
-55,100
| -9% | -$1.53M | 0.05% | 116 |
|
|
2023
Q4 | $18.4M | Sell |
639,997
-100,880
| -14% | -$3.05M | 0.06% | 103 |
|
|
2023
Q3 | $24.6M | Sell |
740,877
-291,178
| -28% | -$10.3M | 0.09% | 89 |
|
|
2023
Q2 | $37.9M | Sell |
1,032,055
-43,883
| -4% | -$1.71M | 0.14% | 68 |
|
|
2023
Q1 | $43.9M | Sell |
1,075,938
-37,500
| -3% | -$1.62M | 0.17% | 60 |
|
|
2022
Q4 | $57.1M | Sell |
1,113,438
-11,152
| -1% | -$535K | 0.21% | 53 |
|
|
2022
Q3 | $49.2M | Buy |
1,124,590
+8,583
| +0.8% | +$417K | 0.21% | 57 |
|
|
2022
Q2 | $58.5M | Sell |
1,116,007
-9,579
| -0.9% | -$488K | 0.24% | 51 |
|
|
2022
Q1 | $58.3M | Buy |
1,125,586
+36,952
| +3% | +$1.92M | 0.19% | 59 |
|
|
2021
Q4 | $64.3M | Sell |
1,088,634
-15,100
| -1% | -$748K | 0.21% | 58 |
|
|
2021
Q3 | $47.5M | Sell |
1,103,734
-11,383
| -1% | -$504K | 0.17% | 67 |
|
|
2021
Q2 | $43.7M | Sell |
1,115,117
-7,741
| -0.7% | -$301K | 0.16% | 70 |
|
|
2021
Q1 | $40.7M | Sell |
1,122,858
-10,665
| -0.9% | -$379K | 0.18% | 73 |
|
|
2020
Q4 | $41.7M | Sell |
1,133,523
-88,862
| -7% | -$3.26M | 0.2% | 68 |
|
|
2020
Q3 | $42.6M | Sell |
1,222,385
-386,645
| -24% | -$13.6M | 0.22% | 63 |
|
|
2020
Q2 | $49.9M | Sell |
1,609,030
-490,215
| -23% | -$16.7M | 0.29% | 53 |
|
|
2020
Q1 | $65M | Sell |
2,099,245
-1,103,113
| -34% | -$37.6M | 0.42% | 40 |
|
|
2019
Q4 | $119M | Sell |
3,202,358
-237,760
| -7% | -$8.47M | 0.6% | 35 |
|
|
2019
Q3 | $117M | Sell |
3,440,118
-858,558
| -20% | -$31.2M | 0.65% | 29 |
|
|
2019
Q2 | $177M | Sell |
4,298,676
-360,762
| -8% | -$14.3M | 0.98% | 17 |
|
|
2019
Q1 | $188M | Sell |
4,659,438
-241,372
| -5% | -$9.67M | 1.08% | 16 |
|
|
2018
Q4 | $203M | Sell |
4,900,810
-271,182
| -5% | -$11.3M | 1.26% | 13 |
|
|
2018
Q3 | $216M | Sell |
5,171,992
-183,290
| -3% | -$7.06M | 1.15% | 14 |
|
|
2018
Q2 | $184M | Buy |
5,355,282
+54,447
| +1% | +$1.86M | 1.06% | 18 |
|
|
2018
Q1 | $178M | Sell |
5,300,835
-41,066
| -0.8% | -$1.41M | 1.02% | 17 |
|
|
2017
Q4 | $184M | Buy |
5,341,901
+6,868
| +0.1% | +$234K | 1.01% | 17 |
|
|
2017
Q3 | $181M | Buy |
5,335,033
+5,673
| +0.1% | +$182K | 1.03% | 16 |
|
|
2017
Q2 | $170M | Sell |
5,329,360
-180,363
| -3% | -$5.69M | 0.99% | 20 |
|
|
2017
Q1 | $179M | Buy |
5,509,723
+59,412
| +1% | +$1.87M | 1.06% | 19 |
|
|
2016
Q4 | $168M | Buy |
5,450,311
+616,271
| +13% | +$18.8M | 1.02% | 18 |
|
|
2016
Q3 | $155M | Sell |
4,834,040
-48,101
| -1% | -$1.61M | 0.95% | 19 |
|
|
2016
Q2 | $163M | Sell |
4,882,141
-3,903,648
| -44% | -$125M | 1% | 19 |
|
|
2016
Q1 | $247M | Buy |
8,785,789
+4,923,294
| +127% | +$141M | 1.52% | 14 |
|
|
2015
Q4 | $118M | Buy |
3,862,495
+2,123,197
| +122% | +$66.8M | 0.73% | 29 |
|
|
2015
Q3 | $51.8M | Buy |
1,739,298
+147,393
| +9% | +$4.73M | 0.33% | 53 |
|
|
2015
Q2 | $50.6M | Sell |
1,591,905
-17,422
| -1% | -$568K | 0.3% | 63 |
|
|
2015
Q1 | $53.1M | Sell |
1,609,327
-27,867
| -2% | -$886K | 0.31% | 60 |
|
|
2014
Q4 | $48.4M | Sell |
1,637,194
-13,099
| -0.8% | -$376K | 0.27% | 69 |
|
|
2014
Q3 | $46.3M | Sell |
1,650,293
-31,244
| -2% | -$877K | 0.27% | 73 |
|
|
2014
Q2 | $47.4M | Sell |
1,681,537
-103,377
| -6% | -$2.95M | 0.3% | 72 |
|
|
2014
Q1 | $54.4M | Buy |
1,784,914
+7,848
| +0.4% | +$234K | 0.36% | 61 |
|
|
2013
Q4 | $51.6M | Sell |
1,777,066
-10,183
| -0.6% | -$296K | 0.34% | 61 |
|
|
2013
Q3 | $48.7M | Buy |
1,787,249
+7,844
| +0.4% | +$213K | 0.34% | 62 |
|
|
2013
Q2 | $49.9M | Buy |
+1,779,405
| New | +$49.2M | 0.34% | 59 |
|
Other funds holding PFE
VCM
VPM
First Manhattan's PFE Position: Q1 2026 in Review
First Manhattan reduced its Pfizer (PFE) stake by 4% in Q1 2026, selling an estimated $200K and leaving 182,334 shares worth $5.12M. The position accounts for 0.01% of the portfolio, ranked #238.
First Manhattan first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $247M in Q1 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- First Manhattan held 182,334 shares of Pfizer worth $5.12M as of Q1 2026.
- First Manhattan sold 7,527 Pfizer shares in Q1 2026, an estimated $200K.
- Pfizer made up 0.01% of First Manhattan's portfolio in Q1 2026, its #238 holding.
- First Manhattan first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- First Manhattan's Pfizer position peaked at $247M in Q1 2016.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.